Arthritis

There are over 100 disorders that typically affect joints, tendons, ligaments, bones, and muscles and are termed arthritis and rheumatic diseases. Some of these may also involve internal organs.

What is Arthritis?

There are over 100 disorders that typically affect joints, tendons, ligaments, bones, and muscles and are termed arthritis and rheumatic diseases. Some of these may also involve internal organs.

Does Drinking Alcohol Cause Joint Pain in Arthritis?

Osteoarthritis vs. Rheumatoid Arthritis – Understanding the Differences

Does Stem Cell Treatment for Arthritis Work?

Most Common Types of Arthritis

Can Antibiotics Increase the Risk of Arthritis?

Does CBD Oil Work for Arthritis Pain?

Physiotherapy as a Treatment for Arthritis

See more featured articles »

Living with Rheumatoid Arthritis

Does Reflexology and Massage Help with Arthritis?

Bursitis and Osteoarthritis Similarities and Differences

Does Poor Sleep Worsen Arthritis?

Latest Arthritis News and Research

Scientists discover how muscle stem cells "flip a switch" to rebuild damaged muscle

Scientists at the University of California, Irvine's School of Pharmacy & Pharmaceutical Sciences have discovered how muscle stem cells "flip a switch" to rebuild damaged muscle – a finding that could help address muscle loss linked to aging, injury and widely used weight-loss medications.

27 Feb 2026

Targeted PET/CT tracer improves early prediction of treatment response in rheumatoid arthritis patients

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research published in The Journal of Nuclear Medicine.

27 Feb 2026

Tick-derived protein discovery can advance treatment for inflammatory diseases

When the immune system detects a harmful or foreign agent it triggers an inflammatory response small proteins called chemokines direct immune cells to the site of the injury or infection, resulting in the invader being inactivated.

27 Feb 2026

Privacy-focused AI improves screening for rare endocrinological condition

An AI can accurately diagnose a rare endocrinological condition just by analyzing pictures of the back of the hand and the clenched fist.

27 Feb 2026

He needs an expensive drug. A copay card helped — until it didn’t.

Over the course of 2025, Jayant Mishra of Mission Viejo, California, progressively developed scaly, itchy red patches on his skin. Then came the pain and swelling in the joints of his hands, making it difficult to do his work at a bank.

27 Feb 2026

Solving the mystery of a year-long pain crisis

Taffy Hopkins, 73, was in debilitating pain for a year, leaving her bedridden. The Palm Beach resident had been told she was simply experiencing migraines, but the migraine medications did not work and left her suffering, with no answers in sight. After seeking care at NYU Langone Medical Associates—West Palm Beach, 1515 North Flagler Drive, she finally received a diagnosis—and relief.

26 Feb 2026

Single prenatal exposure to fungicide linked to disease across 20 generations

A single exposure to a toxic fungicide during pregnancy can increase the risk of disease for 20 subsequent generations - with inherited health problems worsening many generations after exposure.

20 Feb 2026

Macrophage immune memory depends on lingering interferon gamma

Researchers from the University of California, Los Angeles, have discovered that immune cells known as macrophages remain poised to fight repeat infections due to the persistent presence of signaling molecules left behind during previous infections.

18 Feb 2026

Unlocking the potential of phytochemicals in rheumatoid arthritis treatment

Announcing a new article publication for BIO Integration journal. In recent years, phytochemicals and medicinal plants have increasingly been used to treat autoimmune diseases, such as rheumatoid arthritis (RA).

16 Feb 2026

Diacerein shows promise as disease-modifying therapy in rheumatoid arthritis

Announcing a new publication for Acta Materia Medica journal. Diacerein, an anthraquinone derivative, is emerging as a promising disease-modifying agent in rheumatoid arthritis (RA), because of its potent anti-inflammatory and chondroprotective actions.

13 Feb 2026

AI predicts walking recovery after hip replacement surgery

Artificial intelligence can help to predict how well patients with hip osteoarthritis will be able to walk again after an operation.

12 Feb 2026

New Medicaid work rules likely to hit middle-aged adults hard

Lori Kelley's deteriorating vision has made it hard for her to find steady work.

11 Feb 2026

Stress hormones rewire immune system during periods of food scarcity

When food is scarce, stress hormones direct the immune system to operate in "low power" mode to preserve immune function while conserving energy, according to researchers at Weill Cornell Medicine.

10 Feb 2026

Electroacupuncture relieves pain-induced anxiety through prefrontal neural circuits

Neuropathic pain, caused by injury or disease of the somatosensory nervous system, is a major clinical challenge and often evolves into a chronic condition.

7 Feb 2026

Griffith researchers on the cusp of new vaccine to prevent chikungunya

Griffith University researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue.

6 Feb 2026

EBV-linked killer T cells implicated in multiple sclerosis

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million Americans.

5 Feb 2026

Study maps highest hemochromatosis risk in Celtic populations

People from the Outer Hebrides and north-west Ireland have the highest risk of developing a genetic disease that causes a dangerous build-up of iron in the body, a study suggests.

3 Feb 2026

Diabetes drug use linked to fewer gout treatments

Natalie McCormick, PhD, of the Rheumatology and Allergy Clinical Epidemiology Research (RACER) Center within the Division of Rheumatology in the Mass General Brigham Department of Medicine, is the lead author of a paper published in Diabetes Care, "Gout-Related Medication Use After Initiating Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies."

2 Feb 2026

When health insurance costs more than the mortgage

When Noah Hulsman, who owns a skate shop in Louisville, Kentucky, learned he no longer qualified for federal subsidies to help him pay for his "gold" Affordable Care Act health plan, the 37-year-old opted for skimpier coverage. But the deductible is about a quarter of his yearly income.

2 Feb 2026

Research uncovers alternative inflammatory pathway in rheumatoid arthritis treatment

The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, but they don't work for up to 4 of every 10 patients.

30 Jan 2026